The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations
Bullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous diseases. BP characteristically affects the elderly and is seen mainly in patients older than 70 years. While the annual incidence of BP has been estimated to be between 2.4 and 23 cases per million in the general pop...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2018.00220/full |
id |
doaj-89ab2ca0a4524daaaee09fed7678a810 |
---|---|
record_format |
Article |
spelling |
doaj-89ab2ca0a4524daaaee09fed7678a8102020-11-24T23:14:19ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2018-08-01510.3389/fmed.2018.00220402946The Growing Incidence of Bullous Pemphigoid: Overview and Potential ExplanationsKhalaf Kridin0Ralf J. Ludwig1Department of Dermatology, Rambam Health Care Campus, Haifa, IsraelLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, GermanyBullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous diseases. BP characteristically affects the elderly and is seen mainly in patients older than 70 years. While the annual incidence of BP has been estimated to be between 2.4 and 23 cases per million in the general population, it rises exponentially to 190–312 cases per million in individuals older than 80 years. In addition, a growing body of evidence reports a remarkable trend of increased incidence of BP, showing a 1.9- to 4.3-fold rise over the past two decades. This demonstrable increase warrants a higher awareness of the increased risk to develop BP. This review summarizes the current understanding of the epidemiological features of BP and sheds light on the putative explanations for its growing incidence.https://www.frontiersin.org/article/10.3389/fmed.2018.00220/fullbullous pemphigoidepidemiologyexplanationreview of literatureincidenceDPP-4 inhibitors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Khalaf Kridin Ralf J. Ludwig |
spellingShingle |
Khalaf Kridin Ralf J. Ludwig The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations Frontiers in Medicine bullous pemphigoid epidemiology explanation review of literature incidence DPP-4 inhibitors |
author_facet |
Khalaf Kridin Ralf J. Ludwig |
author_sort |
Khalaf Kridin |
title |
The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations |
title_short |
The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations |
title_full |
The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations |
title_fullStr |
The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations |
title_full_unstemmed |
The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations |
title_sort |
growing incidence of bullous pemphigoid: overview and potential explanations |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2018-08-01 |
description |
Bullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous diseases. BP characteristically affects the elderly and is seen mainly in patients older than 70 years. While the annual incidence of BP has been estimated to be between 2.4 and 23 cases per million in the general population, it rises exponentially to 190–312 cases per million in individuals older than 80 years. In addition, a growing body of evidence reports a remarkable trend of increased incidence of BP, showing a 1.9- to 4.3-fold rise over the past two decades. This demonstrable increase warrants a higher awareness of the increased risk to develop BP. This review summarizes the current understanding of the epidemiological features of BP and sheds light on the putative explanations for its growing incidence. |
topic |
bullous pemphigoid epidemiology explanation review of literature incidence DPP-4 inhibitors |
url |
https://www.frontiersin.org/article/10.3389/fmed.2018.00220/full |
work_keys_str_mv |
AT khalafkridin thegrowingincidenceofbullouspemphigoidoverviewandpotentialexplanations AT ralfjludwig thegrowingincidenceofbullouspemphigoidoverviewandpotentialexplanations AT khalafkridin growingincidenceofbullouspemphigoidoverviewandpotentialexplanations AT ralfjludwig growingincidenceofbullouspemphigoidoverviewandpotentialexplanations |
_version_ |
1725595038611668992 |